• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生对公共初级保健诊所老年患者药物减量的认知障碍和促进因素:一项定性研究。

Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.

机构信息

National Poison Centre, Universiti Sains Malaysia, 11800 USM, Pulau Pinang, Malaysia.

School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Pulau Pinang, Malaysia.

出版信息

Int J Clin Pharm. 2022 Feb;44(1):201-213. doi: 10.1007/s11096-021-01336-w. Epub 2021 Oct 12.

DOI:10.1007/s11096-021-01336-w
PMID:34642869
Abstract

Background Increased harmful effects of medication resulting from polypharmacy, especially among older patients, is a significant concern globally. Hence, continuous medication review and withdrawal of inappropriate medications are essential to improve patient safety. Objective To explore physicians' perceived barriers and enablers of deprescribing among older patients in the public primary healthcare setting. Setting Public primary care clinics in the northern states of Malaysia. Methods A semi-structured, face-to-face interview was conducted among physicians working in eight primary care clinics in northern Malaysia using a purposive sampling approach. Interviews were conducted using validated topic guides. All the responses were recorded, transcribed verbatim, validated, and analysed for the emerging themes using thematic analysis. Main outcome measure Physicians perceived barriers and enablers of deprescribing among geriatric patients. Results A total of eleven physicians were interviewed. Seven emerging themes were identified, which are categorised under barriers and enablers of deprescribing. The barriers were patient-specific, prescriber-specific, and healthcare provision and system. Prescriber deprescribing competencies, medication-specific outcomes, availability of empirical evidence, and pharmacist's role were the enablers identified. Conclusion Patient-specific barriers were identified as a significant challenge for deprescribing. Improving competencies on deprescribing was the repeatedly adduced enabler by physicians. The development of targeted educational training can help to reduce the obstacles faced by prescribers.

摘要

背景 由于多种药物治疗(尤其是在老年患者中)导致的药物不良影响增加,这是一个在全球范围内令人严重关切的问题。因此,持续审查药物并停用不适当的药物对于提高患者安全性至关重要。目的 探讨在马来西亚北部公立初级保健环境中,医生对老年患者减少药物治疗的认知障碍和促进因素。地点 马来西亚北部的公立初级保健诊所。方法 采用目的抽样法,对在马来西亚北部 8 家初级保健诊所工作的医生进行了半结构化的面对面访谈。访谈采用经过验证的主题指南进行。对所有的回答进行记录、逐字转录、验证,并使用主题分析对新出现的主题进行分析。主要结果 医生对老年患者减少药物治疗的认知障碍和促进因素。结果 共对 11 名医生进行了访谈。确定了七个新兴主题,这些主题分为减少药物治疗的障碍和促进因素。障碍包括患者特定、医生特定以及医疗保健提供和系统。确定的促进因素包括医生的减少药物治疗能力、药物特定的结果、实证证据的可用性以及药剂师的作用。结论 患者特定的障碍被认为是减少药物治疗的重大挑战。提高减少药物治疗的能力是医生反复提出的促进因素。有针对性的教育培训的发展可以帮助减少医生面临的障碍。

相似文献

1
Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study.医生对公共初级保健诊所老年患者药物减量的认知障碍和促进因素:一项定性研究。
Int J Clin Pharm. 2022 Feb;44(1):201-213. doi: 10.1007/s11096-021-01336-w. Epub 2021 Oct 12.
2
Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.关于老年患者药物减量的知识和意愿:一项定性研究。
Clin Interv Aging. 2018 Aug 6;13:1401-1408. doi: 10.2147/CIA.S165588. eCollection 2018.
3
Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.养老院老年人减药的障碍与促进因素:药剂师独立处方者基于理论的观点。
Res Social Adm Pharm. 2023 May;19(5):746-752. doi: 10.1016/j.sapharm.2023.01.013. Epub 2023 Jan 31.
4
Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.长期护理中减少药物使用的障碍和促进因素:爱尔兰医疗保健专业人员意见的定性调查。
PLoS One. 2022 Dec 15;17(12):e0274552. doi: 10.1371/journal.pone.0274552. eCollection 2022.
5
Enhancing medication management of older adults in Qatar: healthcare professionals' perspectives on challenges, barriers and enabling solutions.加强卡塔尔老年人的药物管理:医疗保健专业人员对挑战、障碍及可行解决方案的看法。
Ther Adv Drug Saf. 2024 Oct 7;15:20420986241272846. doi: 10.1177/20420986241272846. eCollection 2024.
6
Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey.考虑在尼日利亚西南部奥贡州的医疗保健专业人员中停用药物的因素、障碍和促进因素:一项横断面调查。
BMC Health Serv Res. 2024 May 24;24(1):661. doi: 10.1186/s12913-024-11101-0.
7
Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis.老年人及其照护者药物减量的障碍和促进因素:系统评价和元综合。
Eur Geriatr Med. 2023 Dec;14(6):1211-1222. doi: 10.1007/s41999-023-00879-7. Epub 2023 Oct 24.
8
Barriers and enablers to deprescribing in long-term care facilities: a 'best-fit' framework synthesis of the qualitative evidence.长期护理机构中减少药物使用的障碍和促进因素:定性证据的“最佳契合”框架综合分析。
Age Ageing. 2022 Jan 6;51(1). doi: 10.1093/ageing/afab250.
9
Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.关于长期护理中减少用药的居民、家属和医疗保健专业人员的信念和态度:一项定性研究。
Int J Clin Pharm. 2022 Dec;44(6):1370-1379. doi: 10.1007/s11096-022-01419-2. Epub 2022 Oct 6.
10
Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.居家护理护士在药物减量方面的经验探索:一项定性描述性研究。
BMJ Open. 2019 May 24;9(5):e025606. doi: 10.1136/bmjopen-2018-025606.

引用本文的文献

1
Improving the feasibility of deprescribing proton pump inhibitors: GPs' insights on barriers, facilitators, and strategies.提高停用质子泵抑制剂的可行性:全科医生对障碍、促进因素及策略的见解
Front Pharmacol. 2024 Sep 20;15:1468750. doi: 10.3389/fphar.2024.1468750. eCollection 2024.
2
Factors influencing healthcare providers' behaviours in deprescribing: a cross-sectional study.影响医疗服务提供者减药行为的因素:一项横断面研究。
J Pharm Policy Pract. 2024 Sep 16;17(1):2399727. doi: 10.1080/20523211.2024.2399727. eCollection 2024.
3
Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line.

本文引用的文献

1
Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts-Results of a Literature Review.在多重用药定义上未能达成共识:衡量风险和影响的障碍——文献综述结果
Ther Clin Risk Manag. 2020 Feb 11;16:57-73. doi: 10.2147/TCRM.S214187. eCollection 2020.
2
Rationalising medications through deprescribing.通过减药来优化药物治疗
BMJ. 2019 Feb 7;364:l570. doi: 10.1136/bmj.l570.
3
Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
指导社区实践中成功实施减药策略:前线经验教训
Can Pharm J (Ott). 2024 May;157(3):133-142. doi: 10.1177/17151635241240737. Epub 2024 Apr 13.
4
Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review.老年多重用药患者减药的态度和障碍:一项叙述性综述
NPJ Aging. 2024 Jan 23;10(1):6. doi: 10.1038/s41514-023-00132-2.
5
Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia.老年痴呆症患者药物减量决策中的伦理问题。
JAMA Netw Open. 2023 Oct 2;6(10):e2336728. doi: 10.1001/jamanetworkopen.2023.36728.
6
What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.多学科药物审查和减少老年人用药干预措施在初级保健中为何能良好运行?一项实际审查和综合研究。
BMC Geriatr. 2023 Sep 25;23(1):591. doi: 10.1186/s12877-023-04256-8.
7
Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.长期护理中减少药物使用的障碍和促进因素:爱尔兰医疗保健专业人员意见的定性调查。
PLoS One. 2022 Dec 15;17(12):e0274552. doi: 10.1371/journal.pone.0274552. eCollection 2022.
8
Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices.荷兰全科诊所中为老年患者停用降压药物方案的可行性。
BMC Prim Care. 2022 Nov 9;23(1):280. doi: 10.1186/s12875-022-01894-6.
9
Impact of Specialized Clinics on Medications Deprescribing in Older Adults: A Pilot Study in Ambulatory Care Clinics in a Teaching Hospital.专科诊所对老年人减药的影响:教学医院门诊护理诊所的一项试点研究
Saudi Pharm J. 2022 Jul;30(7):1027-1035. doi: 10.1016/j.jsps.2022.04.012. Epub 2022 Apr 30.
10
Implementation of pharmacist-led deprescribing in collaborative primary care settings.在协作式初级保健环境中实施药师主导的药物精简。
Int J Clin Pharm. 2022 Oct;44(5):1216-1221. doi: 10.1007/s11096-022-01449-w. Epub 2022 Jul 6.
养老院老年居民药物减量干预的健康结局:系统评价和荟萃分析。
J Am Med Dir Assoc. 2019 Mar;20(3):362-372.e11. doi: 10.1016/j.jamda.2018.10.026. Epub 2018 Dec 21.
4
Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.关于老年患者药物减量的知识和意愿:一项定性研究。
Clin Interv Aging. 2018 Aug 6;13:1401-1408. doi: 10.2147/CIA.S165588. eCollection 2018.
5
Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.老年住院患者撤药干预对处方和临床结局的影响:随机试验的系统评价
Drugs Aging. 2018 Apr;35(4):303-319. doi: 10.1007/s40266-018-0536-4.
6
Variation of polypharmacy in older primary care attenders occurs at prescriber level.老年初级保健就诊者的多种药物治疗变化发生在开处方者层面。
BMC Geriatr. 2018 Feb 23;18(1):59. doi: 10.1186/s12877-018-0750-2.
7
Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis.系列:定性研究实用指南。第 3 部分:抽样、数据收集和分析。
Eur J Gen Pract. 2018 Dec;24(1):9-18. doi: 10.1080/13814788.2017.1375091. Epub 2017 Dec 4.
8
Information Transfer and the Hospital Discharge Summary: National Primary Care Provider Perspectives of Challenges and Opportunities.信息传递与医院出院小结:国家基层医疗服务提供者对挑战与机遇的看法
J Am Board Fam Med. 2017 Nov-Dec;30(6):758-765. doi: 10.3122/jabfm.2017.06.170194.
9
Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.重度抑郁症门诊患者对抗抑郁药物依从性的障碍与促进因素:一项定性研究。
PLoS One. 2017 Jun 14;12(6):e0179290. doi: 10.1371/journal.pone.0179290. eCollection 2017.
10
GPs' perspectives on prescribing for older people in primary care: a qualitative study.全科医生对基层医疗中老年人处方开具的看法:一项定性研究。
Br J Clin Pharmacol. 2017 Jul;83(7):1521-1531. doi: 10.1111/bcp.13233. Epub 2017 Feb 8.